Medical Officer, Cornea and Refractive Services, Aravind Eye Hospital, Tirunelveli, Tamil Nadu, India.
HOD and Professor, Cornea and Refractive Services, Aravind Eye Hospital, Tirunelveli, Tamil Nadu, India.
Indian J Ophthalmol. 2023 Feb;71(2):498-502. doi: 10.4103/ijo.IJO_1368_22.
To analyze the impact on eye donation and corneal transplantation during the COVID-19 pandemic in a tertiary eye hospital in south India.
A retrospective analysis of the donor and recipient records during the study period from January 2020 to May 2021 was conducted and tabulated in Microsoft Excel 2013. Demographic details of the donor, utility rate, cause of death, culture characteristics, storage methods, wet lab usage, and the surgical donor outcomes were evaluated. Additionally, the postoperative workup of the recipients, diagnosis, graft infection and rejection episodes, development of COVID-19 postoperatively, and outcome in terms of visual acuity at one, three, and six months were also noted.
A total of 466 eyes from 249 donors were received during the study period. The mean age of the donor population was 62.43 years (20.9). The corneal transplantation utility rate was 36.4% (n = 170). Fifty-one percent of the total transplant surgeries were for therapeutic purposes. This was followed by penetrating optical keratoplasty (34%), Descemet's stripping endothelial keratoplasty (9%), and patch grafts (3%). Seventeen (10%) graft rejection episodes were noted and nine (53%) had complete resolution after medical treatment.
Proper preventive measures are key to carrying out safe and efficient eye banking activities even during a deadly pandemic, as COVID-19 transmission via transplantation is rare.
分析 COVID-19 大流行期间印度南部一家三级眼科医院的眼库捐赠和角膜移植的影响。
对 2020 年 1 月至 2021 年 5 月研究期间的供体和受体记录进行回顾性分析,并在 Microsoft Excel 2013 中进行列表。评估供体的人口统计学细节、利用率、死因、培养特性、储存方法、湿实验室使用情况和手术供体结果。此外,还记录了受体的术后检查、诊断、移植物感染和排斥发作、术后 COVID-19 的发展以及术后 1、3 和 6 个月的视力结局。
在研究期间共接收了 249 名供体的 466 只眼睛。供体人群的平均年龄为 62.43 岁(20.9)。角膜移植利用率为 36.4%(n=170)。51%的总移植手术是出于治疗目的。其次是穿透性光学角膜移植术(34%)、撕囊内皮角膜移植术(9%)和补丁移植术(3%)。注意到 17 次(10%)移植物排斥发作,其中 9 次(53%)经药物治疗后完全缓解。
即使在致命的大流行期间,采取适当的预防措施对于开展安全有效的眼库活动也至关重要,因为 COVID-19 通过移植传播的情况很少见。